公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
公司地址 400 Crossing Boulevard, 3rd Floor, Bridgewater, NJ, USA, 08807
電話號碼 +1 908 947-3120
傳真號碼 +1 908 947-3146
公司網頁 https://www.amneal.com
員工數量 8500
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Anastasios G. Konidaris Principal Accounting Officer, Executive Vice President and Chief Financial Officer 美元 600.75K 25/03/2026
Mr. Andrew S. Boyer Executive Vice President and Chief Commercial Officer, Generics 美元 613.85K 25/03/2026
Mr. Chirag Patel Director, Co-Chief Executive Officer and President 美元 800.00K 25/03/2026
Mr. Chintu Patel Director and Co-Chief Executive Officer 美元 800.00K 25/03/2026
Ms. Nikita Shah Executive Vice President and Chief Human Resources Officer 美元 518.78K 25/03/2026
Mr. Jason B. Daly Executive Vice President, Chief Legal Officer and Corporate Secretary 美元 560.02K 25/03/2026
 
董事會成員
董事會 職務 更新日期
Mr. J. Kevin Buchi Independent Director 25/03/2026
Mr. Ted C. Nark Independent Director 25/03/2026
Mr. Paul M. Meister Chairman of the Board 25/03/2026
Mr. Shlomo Yanai Independent Director 25/03/2026
Mr. Chirag Patel Director, Co-Chief Executive Officer and President 25/03/2026
Mr. Chintu Patel Director and Co-Chief Executive Officer 25/03/2026
Mr. Gautam Patel Independent Director 25/03/2026
Mr. John J. Kiely, Jr Independent Director 25/03/2026
Mr. Jeffrey P. George Independent Director 25/03/2026
Ms. Deborah M. Autor Independent Director 25/03/2026
 
所屬ETF (更新日期: 25/04/2026 04:40)
代號 名稱 佔比% 持有日期
IJRiShares Core S&P Small-Cap ETF3.24%31/03/2026
IWMiShares Russell 2000 ETF1.16%31/03/2026
SPSMState Street SPDR Port S&P 600 Sm CpETF0.49%31/03/2026
XSMOInvesco S&P SmallCap Momentum ETF0.44%31/03/2026
IWOiShares Russell 2000 Growth ETF0.34%31/03/2026
DFASDimensional US Small Cap ETF0.32%31/03/2026
IJTiShares S&P Small-Cap 600 Growth ETF0.28%31/03/2026
SCHASchwab US Small-Cap ETF™0.26%31/03/2026
PJPInvesco Pharmaceuticals ETF0.26%31/03/2026
VTWOVanguard Russell 2000 ETF0.24%31/03/2026
IJSiShares S&P Small-Cap 600 Value ETF0.21%31/03/2026
FESMFidelity Enhanced Small Cap ETF0.21%31/03/2026
VIOOVanguard S&P Small-Cap 600 ETF0.18%31/03/2026
SLYGState Street® SPDR® S&P 600™ Sm Cp GrETF0.17%31/03/2026
IHEiShares US Pharmaceuticals ETF0.15%31/03/2026
VHTVanguard Health Care ETF0.15%31/03/2026
XPHState Street® SPDR® S&P® PhrmctlsETF0.15%31/03/2026
DFACDimensional US Core Equity 2 ETF0.14%31/03/2026
FYCFirst Trust Small Cap Gr AlphaDEX® ETF0.14%31/03/2026
USVMVictoryShares US Sm Md Cp Val Momt ETF0.14%31/03/2026
 1    2    3    4    5    6  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.